OpenVSafe by OpenVAERS
Search V-safe

AZY-29974-49220

5 vaccinations 6 coded responses 24 check-ins 6 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
483 / MI
Registered
2021-01-15
Relationship
Self
Race
N/A
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-15
    Registered in v-safe
  2. 2021-01-15
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Condition aggravated, Cough — Feeling: Good
    Free text: Slight increase in the frequency of my chronic cough.About the same as I reported last time.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cough, Dyspnoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Some increase in shortness of breath and coughing requiring more frequent use of albuterol inhaler. Used to be every 2 to 3 hours. Now it is 2 puffs every hour.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-17
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cough, Dyspnoea — Feeling: Fair
    Free text: Same as last report: increased frequency of cough. Having to use albuterol more frequently.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cough — Feeling: Fair
    Free text: Some increase in coughing, as stated before, requiring more frequent use of albuterol inhaler.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-22
    Health check-in — day 7, dose 1
    Feeling: Fair · None
    Adult check-in
  9. 2021-02-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-04
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-03-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-06
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-08-07
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-08-26
    Dose 3 — Pfizer-BioNTech
  18. 2022-01-27
    Dose 4 — Pfizer-BioNTech
  19. 2022-02-04
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-02-04
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  21. 2022-02-10
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  22. 2022-02-17
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  23. 2022-02-26
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  24. 2022-03-05
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  25. 2022-03-10
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  26. 2022-04-28
    Survey response — 3 months, dose 4
    MedDRA: Cough, Decreased appetite, Productive cough, Respiratory symptom, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Had URI type of symptoms with clear rhinorrea. Some coughing and expectoration of phlegm. No fever or chills. Some decrease in appetite. No nausea or vomiting.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-07-13
    Dose 5 — Pfizer-BioNTech
  28. 2022-07-28
    Survey response — 6 months, dose 4
    MedDRA: Computerised tomogram abnormal, Culture positive, Office visit, Productive cough, Pseudomonas infection, Respiratory tract infection, Upper respiratory tract infection — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: URI infection with more frequent cough and productive sputum. CT chest: Abnormal findings suggestive of respiratory infection. Treated for 10 days of oral cephalosporin. Follow up CT some improvement. Culture positive for mucoid pseudomonas. ID cons. · Healthcare visit (other): Visit with Infectious Disease consultant.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-07-28
    Report sent to call center — 6 months, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2022-07-29
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  31. 2022-08-12
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  32. 2022-08-19
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  33. 2023-01-12
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Pfizer-BioNTech
22021-02-04Pfizer-BioNTech
32021-08-26Pfizer-BioNTech No
42022-01-27Pfizer-BioNTech No
52022-07-13Pfizer-BioNTech No

Call center

2 call center cases

1 successful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-16

Systemic reaction (other): Slight increase in the frequency of my chronic cough.About the same as I reported last time.

2021-01-17

Systemic reaction (other): Some increase in shortness of breath and coughing requiring more frequent use of albuterol inhaler. Used to be every 2 to 3 hours. Now it is 2 puffs every hour.

2021-01-18

Systemic reaction (other): Same as last report: increased frequency of cough. Having to use albuterol more frequently.

2021-01-21

Systemic reaction (other): Some increase in coughing, as stated before, requiring more frequent use of albuterol inhaler.

Release 11 — 3 months, dose 4

2022-04-28

Symptoms: Had URI type of symptoms with clear rhinorrea. Some coughing and expectoration of phlegm. No fever or chills. Some decrease in appetite. No nausea or vomiting.

Release 12 — 6 months, dose 4

2022-07-28

Symptoms: URI infection with more frequent cough and productive sputum. CT chest: Abnormal findings suggestive of respiratory infection. Treated for 10 days of oral cephalosporin. Follow up CT some improvement. Culture positive for mucoid pseudomonas. ID cons. cut off by CDC
Healthcare visit (other): Visit with Infectious Disease consultant.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDComputerised tomogram abnormal · · ✓
SDCough · · ✓
SDCulture positive · · ✓
SDDecreased appetite · · ✓
SDOffice visit · · ✓
SDProductive cough · · ✓
SDPseudomonas infection · · ✓
SDRespiratory symptom · · ✓
SDRespiratory tract infection · · ✓
SDRhinorrhoea · · ✓
SDUpper respiratory tract infection · · ✓
SROCondition aggravated ✓ ✓ ✓
SROCough ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release